Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials. [electronic resource]
Producer: 20140220Description: 714-27 p. digitalISSN:- 2213-2600
- Administration, Inhalation
- Adult
- Aged
- Asthma -- drug therapy
- Female
- Follow-Up Studies
- Forced Expiratory Volume -- drug effects
- Healthy Volunteers
- Humans
- Isoquinolines -- administration & dosage
- Male
- Middle Aged
- Nebulizers and Vaporizers
- Phosphodiesterase 3 Inhibitors -- administration & dosage
- Phosphodiesterase 4 Inhibitors -- administration & dosage
- Prospective Studies
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Pyrimidinones -- administration & dosage
- Single-Blind Method
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.